Toviaz

Product NDC: 0069-0242
11-digit product format: 000690242
Labeler code: 0069
Product ID: 0069-0242_ca2031f1-5425-4d31-bf14-c865ec4e89b7
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: fesoterodine fumarate
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Route: ORAL
Labeler: Pfizer Laboratories Div Pfizer Inc
Application: NDA022030
Marketing category: NDA
Marketing start: 2008-10-31
Substance: FESOTERODINE FUMARATE
Active strength: 4 mg/1
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N022030-001	TOVIAZ	FESOTERODINE FUMARATE	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31
N022030-002	TOVIAZ	FESOTERODINE FUMARATE	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
N022030-001	AB
N022030-002	AB

Orange Book patents#

Current patent rows page 1 of 1 · 12 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N022030-001	7807715	2027-06-07	U-913	Drug product
N022030-001	8088398	2027-06-07	U-913	Drug product
N022030-001	8501723	2027-06-07		Drug product	2013-08-20
N022030-001	7807715*PED	2027-12-07		Pediatric extension
N022030-001	8088398*PED	2027-12-07		Pediatric extension
N022030-001	8501723*PED	2027-12-07		Pediatric extension
N022030-002	7807715	2027-06-07	U-913	Drug product
N022030-002	8088398	2027-06-07	U-913	Drug product
N022030-002	8501723	2027-06-07		Drug product	2013-08-20
N022030-002	7807715*PED	2027-12-07		Pediatric extension
N022030-002	8088398*PED	2027-12-07		Pediatric extension
N022030-002	8501723*PED	2027-12-07		Pediatric extension

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-01 22:54:32	2026-06	N022030-001	TOVIAZ	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N022030-002	TOVIAZ	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-01 22:54:32	2026-06	N022030-001	AB	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N022030-002	AB	1	`a50c72e98297…`

Observed Orange Book patent history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-08-01 22:54:32	2026-06	N022030-001	7807715	2027-06-07	U-913	Drug product		`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N022030-001	8088398	2027-06-07	U-913	Drug product		`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N022030-001	8501723	2027-06-07		Drug product	2013-08-20	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N022030-001	7807715*PED	2027-12-07		Pediatric extension		`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N022030-001	8088398*PED	2027-12-07		Pediatric extension		`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N022030-001	8501723*PED	2027-12-07		Pediatric extension		`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N022030-002	7807715	2027-06-07	U-913	Drug product		`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N022030-002	8088398	2027-06-07	U-913	Drug product		`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N022030-002	8501723	2027-06-07		Drug product	2013-08-20	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N022030-002	7807715*PED	2027-12-07		Pediatric extension		`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N022030-002	8088398*PED	2027-12-07		Pediatric extension		`a50c72e98297…`
2026-08-01 22:54:32	2026-06	N022030-002	8501723*PED	2027-12-07		Pediatric extension		`a50c72e98297…`

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Toviaz	FESOTERODINE FUMARATE	Pfizer Laboratories Div Pfizer Inc	5be745f0-8ae7-4c3c-9962-37d6263326f1	2026-04-07	Warnings, Adverse reactions	Exact identifier application applno (NDA): 022030 application number: NDA022030 ndc (product): 0069-0242

Additional Listing Data#

Finished product: Yes
Brand name base: Toviaz
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
FESOTERODINE FUMARATE	4 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
EOS72165S7	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
810071	Internal RxNorm lookup
810075	Internal RxNorm lookup
810077	Internal RxNorm lookup
810079	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
5be745f0-8ae7-4c3c-9962-37d6263326f1	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
929b9598-46e7-5b66-7a86-5544524fb173	Product name	6	20240208
351abe41-466c-4dd8-840a-0fdb68318bd5	Product name	1	20230316

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
0069-0242-30	2024-01-30	C162847	48780-1	1030e365-5eae-111a-e063-dadaa90a10e2	These highlights do not include all the information needed to use TOVIAZ safely and effectively. See full prescribing information for TOVIAZ. TOVIAZ ® (fesoterodine fumarate) extended-release tablets, for oral use Initial U.S. Approval: 2008

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0069-0242-30	Toviaz	30 in 1 BOTTLE	TABLET, FILM COATED, EXTENDED RE	30		33

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0069-0242-30	EA - Each	0069-0242	7beb37be-b5c7-43f0-b53b-7a582db41e75	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
FESOTERODINE FUMARATE	ACTIVE INGREDIENT	EOS72165S7	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
FESOTERODINE	ACTIVE MOIETY	621G617227	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
GLYCERYL DIBEHENATE	INACTIVE INGREDIENT	R8WTH25YS2	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
INDIGOTINDISULFONATE SODIUM	INACTIVE INGREDIENT	D3741U8K7L	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
LECITHIN, SOYBEAN	INACTIVE INGREDIENT	1DI56QDM62	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
XYLITOL	INACTIVE INGREDIENT	VCQ006KQ1E	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
fesoterodine fumarate	ACTIVE INGREDIENT	EOS72165S7	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
fesoterodine	ACTIVE MOIETY	621G617227	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
aluminum oxide	INACTIVE INGREDIENT	LMI26O6933	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
cellulose, microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
glyceryl behenate	INACTIVE INGREDIENT	R8WTH25YS2	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
hypromelloses	INACTIVE INGREDIENT	3NXW29V3WO	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
indigotindisulfonate sodium	INACTIVE INGREDIENT	D3741U8K7L	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
lactose monohydrate	INACTIVE INGREDIENT	EWQ57Q8I5X	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
lecithin, soybean	INACTIVE INGREDIENT	1DI56QDM62	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
polyethylene glycols	INACTIVE INGREDIENT	3WJQ0SDW1A	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
polyvinyl alcohol	INACTIVE INGREDIENT	532B59J990	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
talc	INACTIVE INGREDIENT	7SEV7J4R1U	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
xylitol	INACTIVE INGREDIENT	VCQ006KQ1E	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
FESOTERODINE FUMARATE	ACTIVE INGREDIENT	EOS72165S7	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
FESOTERODINE	ACTIVE MOIETY	621G617227	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
GLYCERYL DIBEHENATE	INACTIVE INGREDIENT	R8WTH25YS2	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
INDIGOTINDISULFONATE SODIUM	INACTIVE INGREDIENT	D3741U8K7L	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
LECITHIN, SOYBEAN	INACTIVE INGREDIENT	1DI56QDM62	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
XYLITOL	INACTIVE INGREDIENT	VCQ006KQ1E	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0069-0242	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	32	Current NDC, Legacy NDC, 1 package rows	20241215_5be745f0-8ae7-4c3c-9962-37d6263326f1.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
EOS72165S7	FESOTERODINE FUMARATE	286930-03-8	FESOTERODINE FUMARATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
810071	fesoterodine fumarate 4 MG 24HR Extended Release Oral Tablet	PSN	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810077	fesoterodine fumarate 8 MG 24HR Extended Release Oral Tablet	PSN	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810075	Toviaz 4 MG 24HR Extended Release Oral Tablet	PSN	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810079	Toviaz 8 MG 24HR Extended Release Oral Tablet	PSN	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810075	24 HR fesoterodine fumarate 4 MG Extended Release Oral Tablet [Toviaz]	SBD	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810079	24 HR fesoterodine fumarate 8 MG Extended Release Oral Tablet [Toviaz]	SBD	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810071	24 HR fesoterodine fumarate 4 MG Extended Release Oral Tablet	SCD	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810077	24 HR fesoterodine fumarate 8 MG Extended Release Oral Tablet	SCD	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810075	24 HR Toviaz 4 MG Extended Release Oral Tablet	SY	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810079	24 HR Toviaz 8 MG Extended Release Oral Tablet	SY	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810071	fesoterodine fumarate 4 MG 24 HR Extended Release Oral Tablet	SY	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810077	fesoterodine fumarate 8 MG 24 HR Extended Release Oral Tablet	SY	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810075	Toviaz 4 MG 24 HR Extended Release Oral Tablet	SY	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810079	Toviaz 8 MG 24 HR Extended Release Oral Tablet	SY	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810071	fesoterodine fumarate 4 MG 24HR Extended Release Oral Tablet	PSN	fead426f-b955-4b41-8553-f102d17afa3a	3
810077	fesoterodine fumarate 8 MG 24HR Extended Release Oral Tablet	PSN	fead426f-b955-4b41-8553-f102d17afa3a	3
810075	Toviaz 4 MG 24HR Extended Release Oral Tablet	PSN	fead426f-b955-4b41-8553-f102d17afa3a	3
810079	Toviaz 8 MG 24HR Extended Release Oral Tablet	PSN	fead426f-b955-4b41-8553-f102d17afa3a	3
810075	24 HR fesoterodine fumarate 4 MG Extended Release Oral Tablet [Toviaz]	SBD	fead426f-b955-4b41-8553-f102d17afa3a	3
810079	24 HR fesoterodine fumarate 8 MG Extended Release Oral Tablet [Toviaz]	SBD	fead426f-b955-4b41-8553-f102d17afa3a	3
810071	24 HR fesoterodine fumarate 4 MG Extended Release Oral Tablet	SCD	fead426f-b955-4b41-8553-f102d17afa3a	3
810077	24 HR fesoterodine fumarate 8 MG Extended Release Oral Tablet	SCD	fead426f-b955-4b41-8553-f102d17afa3a	3
810075	24 HR Toviaz 4 MG Extended Release Oral Tablet	SY	fead426f-b955-4b41-8553-f102d17afa3a	3
810079	24 HR Toviaz 8 MG Extended Release Oral Tablet	SY	fead426f-b955-4b41-8553-f102d17afa3a	3
810071	fesoterodine fumarate 4 MG 24 HR Extended Release Oral Tablet	SY	fead426f-b955-4b41-8553-f102d17afa3a	3
810077	fesoterodine fumarate 8 MG 24 HR Extended Release Oral Tablet	SY	fead426f-b955-4b41-8553-f102d17afa3a	3
810075	Toviaz 4 MG 24 HR Extended Release Oral Tablet	SY	fead426f-b955-4b41-8553-f102d17afa3a	3
810079	Toviaz 8 MG 24 HR Extended Release Oral Tablet	SY	fead426f-b955-4b41-8553-f102d17afa3a	3
810071	fesoterodine fumarate 4 MG 24HR Extended Release Oral Tablet	PSN	f79a8796-a5b5-436e-8f94-f13a05eda63f	1
810075	Toviaz 4 MG 24HR Extended Release Oral Tablet	PSN	f79a8796-a5b5-436e-8f94-f13a05eda63f	1
810075	24 HR fesoterodine fumarate 4 MG Extended Release Oral Tablet [Toviaz]	SBD	f79a8796-a5b5-436e-8f94-f13a05eda63f	1
810071	24 HR fesoterodine fumarate 4 MG Extended Release Oral Tablet	SCD	f79a8796-a5b5-436e-8f94-f13a05eda63f	1
810075	24 HR Toviaz 4 MG Extended Release Oral Tablet	SY	f79a8796-a5b5-436e-8f94-f13a05eda63f	1
810071	fesoterodine fumarate 4 MG 24 HR Extended Release Oral Tablet	SY	f79a8796-a5b5-436e-8f94-f13a05eda63f	1
810075	Toviaz 4 MG 24 HR Extended Release Oral Tablet	SY	f79a8796-a5b5-436e-8f94-f13a05eda63f	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0069-0242-30	00069024230	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0242-30)	2008-10-31	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Toviaz	Pfizer Laboratories Div Pfizer Inc \| Pfizer Ireland Pharmaceuticals Unlimited Company \| Pfizer Manufacturing Deutschland GmbH	2026-04-07	HUMAN PRESCRIPTION DRUG LABEL	33
Toviaz	Cardinal Health	2019-11-26	HUMAN PRESCRIPTION DRUG LABEL	6
Toviaz - Avera McKennan Hospital	Avera McKennan Hospital	2015-12-16	HUMAN PRESCRIPTION DRUG LABEL	1
Toviaz - Physicians Total Care, Inc.	Physicians Total Care, Inc.	2012-04-06	HUMAN PRESCRIPTION DRUG LABEL	3